004720 — PharmGen Science Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for PharmGen Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	404	11,209	41,949	89,960	7,991
Depreciation
Amortisation
Non-Cash Items	3,922	-6,230	-39,514	-80,051	-4,065
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,125	-5,266	2,241	-14,522	-2,688
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,523	2,676	7,784	-1,286	5,439
Capital Expenditures	-6,783	-5,463	-34,010	-11,956	-3,292
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-4,172	-2,257	3,625	-3,328	6,552
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-10,955	-7,721	-30,385	-15,284	3,260
Financing Cash Flow Items	-188	70	-176	1,803	297
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,586	19,568	30,340	2,269	8,852
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-11,018	14,523	7,739	-14,302	17,551